EMILY MOWER: Open Payments
NPI 1235854795 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 25 payments from 10 companies in 2025. Trend: 2023 $83 · 2024 $261 · 2025 $654
Food & beverage: $460Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $213 |
| Regeneron Healthcare Solutions, Inc. | 4 | $169 |
| Mallinckrodt Hospital Products Inc. | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| ABBVIE INC. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Organon LLC | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, DUPIXENT, ACTHAR, COSENTYX, SKYRIZI, NEMLUVIO, Bimzelx, Korlym.
Industry payments across OR — which companies pay providers there.
